Report #2899576

Received Jun 10, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: NY
Recovered: Unknown
Vaccinated: Nov 1, 2025
Onset: Jan 1, 2026
Days to onset: 61
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	1	—	—

Symptoms (1)

Extra dose administered

Symptom narrative

The Patient Got HEPLISAV-B and then Got Engerix; Initial report received on 03-Jun-2026. A pharmacist reported that a patient (age, gender, race, and ethnicity not reported) received their first dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and then received ENGERIX-B. No medical history or concomitant medications were received. In Nov-2025, the patient received dose 1of a hepatitis B vaccine [HEPLISAV-B (Lot #, expiration date, NDC #, route, and site not available)]. In Jan-2026, about two months after having been vaccinated with HEPLISAV-B, the patient received a dose of ENGERIX-B (Lot # not reported). Reporter declined to provide further information. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.

Other medications

Engerix b